Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on tariffs on the industry. Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing,

President Trump will host on Wednesday top executives from companies including Nvidia, Johnson & Johnson, Eli Lilly, GE Aerospace and SoftBank, as promotes investment in the U.S., per the White House.